Velsera is a forward-thinking company established in 2023, born from the collaboration of Seven Bridges and Pierian, with a mission to expedite the discovery, development, and delivery of transformative insights in the healthcare sector. Headquartered in Boston, MA, Velsera specializes in providing innovative software and professional services that leverage AI for multimodal data harmonization and analytics, particularly in drug discovery and development, IVD development, and clinical NGS interpretation. The company is committed to fostering a collaborative and inclusive work environment, emphasizing core values such as integrity, curiosity, and a patient-focused approach, while actively seeking to make a positive impact on global health.